CN Patent

CN121013719A — 治疗特发性震颤的方法

Assigned to Praxis Precision Pharmaceuticals · Expires 2025-11-25 · 0y expired

What this patent protects

本公开涉及治疗特发性震颤的方法，所述方法包含向有需要的受试者施用式(I)化合物或其药学上可接受的盐，其中所述式(I)化合物或其药学上可接受的盐以约60 mg至约100 mg的剂量每天一次向所述受试者施用；使得与施用所述式(I)化合物或其药学上可接受的盐之前所述受试者的特发性震颤评级评估量表(The Essential Tremor Rating Assessment Scale；TETRAS)表现评分相比，在施用所述式(I)化合物或其药学上可接受的盐之后，所述受试者的所述TETRAS表现评分降低。 (I)

USPTO Abstract

本公开涉及治疗特发性震颤的方法，所述方法包含向有需要的受试者施用式(I)化合物或其药学上可接受的盐，其中所述式(I)化合物或其药学上可接受的盐以约60 mg至约100 mg的剂量每天一次向所述受试者施用；使得与施用所述式(I)化合物或其药学上可接受的盐之前所述受试者的特发性震颤评级评估量表(The Essential Tremor Rating Assessment Scale；TETRAS)表现评分相比，在施用所述式(I)化合物或其药学上可接受的盐之后，所述受试者的所述TETRAS表现评分降低。 (I)

Drugs covered by this patent

Patent Metadata

Patent number: CN121013719A
Jurisdiction: CN
Classification: —
Expires: 2025-11-25
Drug substance claim: No
Drug product claim: No
Assignee: Praxis Precision Pharmaceuticals
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.